SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-006688
Filing Date
2018-03-23
Accepted
2018-03-23 17:00:15
Documents
2
Period of Report
2018-03-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K orex-8k_20180320.htm 8-K 26576
2 EX-4.1 orex-ex41_6.htm EX-4.1 74183
  Complete submission text file 0001564590-18-006688.txt   101906
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33415 | Film No.: 18710816
SIC: 2834 Pharmaceutical Preparations